Acceder

Publicaciones - INMUNOLOGÍA E INMUNOTOLERANCIA EN TRASPLANTES Y ENFERMEDADES DE BASE INMUNOLÓGICA

Cargando...
Sozio E, Moore NA, Fabris M, Ripoli A, Rumbolo F, Minieri M, Boverio R, Rodriguez Mulero MD, Lainez-Martinez S, Martinez Martinez M, Calvo D, Gregoriano C, Williams R, Brazzi L, Terrinoni A, Callegari T, Hernandez Olivo M, Esteban-Torrella P, Calcerrada I, Bernasconi L, Kidd SP, Sbrana F, Miguens I, Gordon K, Visentini D, Legramante JM, Bassi F, Cortes N, Montrucchio G, Di Lecce VN, Lauritano EC, Garcia de Guadiana-Romualdo L, Gonzalez Del Castillo J, Bernal-Morell E, Andaluz-Ojeda D, Schuetz P, Curcio F, Tascini C, Saeed K. Identification of COVID-19 patients at risk of hospital admission and mortality: a European multicentre retrospective analysis of mid-regional pro-adrenomedullin. Respir Res. 2022 Aug 28;23(1):221. doi: 10.1186/s12931-022-02151-1. PubMed PMID: 36031619; PubMed Central PMCID: PMC9420187.
AÑO: 2022; IF: 7.162
Parrado A, Rubio G, Serrano M, De la Morena-Barrio ME, Ibanez-Mico S, Ruiz-Lafuente N, Schwartz-Albiez R, Esteve-Sole A, Alsina L, Corral J, Hernandez-Caselles T. Dissecting the transcriptional program of phosphomannomutase 2-deficient cells: Lymphoblastoide B cell lines as a valuable model for congenital disorders of glycosylation studies. Glycobiology. 2022 Mar 19;32(2):84-100. doi: 10.1093/glycob/cwab087. PubMed PMID: 34420056.
AÑO: 2022; IF: 4.3
Lopez-Rodriguez R, Del Pozo-Valero M, Corton M, Minguez P, Ruiz-Hornillos J, Perez-Tomas ME, Barreda-Sanchez M, Mancebo E, Villaverde C, Nunez-Moreno G, Romero R; STOP_Coronavirus Study Group; Paz-Artal E, Guillen-Navarro E, Almoguera B, Ayuso C. Presence of rare potential pathogenic variants in subjects under 65 years old with very severe or fatal COVID-19. Sci Rep. 2022 Jun 20;12(1):10369. doi: 10.1038/s41598-022-14035-x. PubMed PMID: 35725860; PubMed Central PMCID: PMC9208539.
AÑO: 2022; IF: 4.6
Torres-Cantero AM, Alvarez Leon EE, Moran-Sanchez I, San Lazaro Campillo I, Bernal Morell E, Hernandez Perena M, Martinez-Morata I. [Health impact of COVID pandemic. SESPAS Report 2022]. Gac Sanit. 2022;36 Suppl 1:S4-S12. doi: 10.1016/j.gaceta.2022.02.008. Spanish. PubMed PMID: 35781147; PubMed Central PMCID: PMC9244867.
AÑO: 2022; IF: 1.9
Ros-Lucas JA, Pascual-Figal DA, Noguera-Velasco JA, Hernandez-Vicente A, Cebreiros-Lopez I, Arnaldos-Carrillo M, Martinez-Ardil IM, Garcia-Vazquez E, Aparicio-Vicente M, Solana-Martinez E, Ruiz-Martinez SY, Fernandez-Mula L, Andujar-Espinosa R, Fernandez-Suarez B, Sanchez-Caro MD, Penalver-Mellado C, Ruiz-Lopez FJ. CA 15-3 prognostic biomarker in SARS-CoV-2 pneumonia. Sci Rep. 2022 Apr 25;12(1):6738. doi: 10.1038/s41598-022-10726-7. PubMed PMID: 35469047; PubMed Central PMCID: PMC9037059.
AÑO: 2022; IF: 4.6
< AnteriorSiguiente >

Instituto de Investigación Sanitaria Acreditado

ISCII

INMUNOLOGÍA E INMUNOTOLERANCIA EN TRASPLANTES Y ENFERMEDADES DE BASE INMUNOLÓGICA